{"success":true,"data":{"pressRelease":{"id":"99534","rtpr_id":"nBwbhfMVVa","ticker":"HURN","exchange":"NASDAQ","all_tickers":["HURN"],"title":"Huron Elects Dr. L. Thomas Richards to Board of Directors","author":"Business Wire","published_at":"2026-07-27T20:02:00.134Z","article_body":"Huron Elects Dr. L. Thomas Richards to Board of Directors\n\nGlobal professional services firm Huron (NASDAQ: HURN) today announced Dr. L.\nThomas Richards was elected to its Board of Directors, effective July 23,\n2026. Dr. Richards is an experienced executive, senior advisor and board\nleader with deep expertise across life sciences and healthcare, capital\nmarkets, and corporate governance. He has a proven track record of helping\norganizations drive growth, unlock innovation, and accelerate value creation.\n\n“We are pleased to welcome Tom to Huron's Board of Directors,” said Hugh\nSawyer\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fir.huronconsultinggroup.com%2Fboard-member%2Fhugh-sawyer&esheet=54577833&newsitemid=20260727120166&lan=en-US&anchor=Hugh+Sawyer&index=1&md5=f0af385f7876d06fb2813f7aa189890c)\n, non-executive chairman of the Huron\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.huronconsultinggroup.com%2F&esheet=54577833&newsitemid=20260727120166&lan=en-US&anchor=Huron&index=2&md5=1210928c5cd5166e8563c309bad9284c)\nboard. “Tom brings a unique combination of senior management, board\nleadership, and capital markets expertise across his roles as an investment\nbanker, life sciences executive, physician, and board director. His global\nperspective, and expertise in evaluating and adopting new innovative\ntechnologies, and extensive governance experience in professional services\nwill be a strong asset to our Board as we continue to advance Huron’s growth\nstrategy to create long-term value for our shareholders.”\n\nDr. Richards most recently served as Chair of the Board of Directors of\nWittKieffer, an executive search and leadership advisory firm serving the\nhealthcare, higher education, and life sciences sectors.\n\nThroughout his career, Dr. Richards has led organizations at the intersection\nof healthcare, technology, and innovation. He previously served as Interim\nChief Executive Officer of One Biomed, a molecular tools company, and Chief\nExecutive Officer of TessArae, a molecular diagnostics company. He advises\nventure capital and private equity investors across the life sciences\nindustry, with a focus on emerging technologies and innovation-driven growth\nand served as a Senior Advisor to Metis Genetics, One Biomed, and Nanomix. He\nalso practiced academic medicine as an emergency physician and assistant\nprofessor at Stanford University and the University of California, San\nFrancisco.\n\nEarlier in his career, Dr. Richards was an investment banker in the mergers\nand acquisitions (M&A) groups of Lazard Frères, UBS, and SG Cowen.\n\nDr. Richards also has extensive governance experience serving on public,\nprivate, and nonprofit boards. He previously served on the board of directors\nof Cowen Group, Inc., a publicly traded financial services firm, and has\nserved as a director of TessArae and One Biomed. He also currently serves on\nthe board of two non-profit organizations, The World Telehealth Initiative and\nthe Surfrider Foundation.\n\n“I am honored to serve on Huron’s Board of Directors,” said Dr. L.\nThomas Richards. \"I look forward to partnering with my fellow directors and\nHuron’s management team to build on the firm’s strong momentum, advance\nits long-term strategy, and help create lasting value for its clients, people,\nand shareholders.”\n\nDr. Richards received an M.D. from Harvard Medical School, an M.Phil. from the\nUniversity of Sydney, and a B.A. from Yale University. He is a board-certified\nphysician in Emergency Medicine.\n\nThe appointment of Dr. Richards to Huron’s board reflects the firm’s\nongoing commitment to its periodic board refreshment process and brings the\nsize of the board to 10 members.\n\nABOUT HURON\n\nHuron is a global professional services firm that collaborates with\norganizations to help solve their most complex challenges and achieve their\nmost ambitious goals. Working across the private and public sectors, we\npartner closely with clients to improve performance, accelerate\ntransformation, and unlock new opportunities for growth.\n\nOur clients choose us because of our deep industry and technical expertise and\nproven track record of turning sound strategies into action. By combining\npractical experience, innovative thinking, and advanced analytics and\ntechnology, Huron helps organizations translate today’s ideas into tangible\nresults and long-term value. Learn more at www.huronconsultinggroup.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.huronconsultinggroup.com%2F&esheet=54577833&newsitemid=20260727120166&lan=en-US&anchor=www.huronconsultinggroup.com&index=3&md5=c88fc50818746719b82a0ba21935dd26)\n.\n\nStatements in this press release that are not historical in nature, including\nthose concerning the company’s current expectations about its future\nresults, are “forward-looking” statements as defined in Section 21E of the\nSecurities Exchange Act of 1934, as amended, and the Private Securities\nLitigation Reform Act of 1995. Forward-looking statements are identified by\nwords such as “may,” “should,” “expects,” “provides,”\n“anticipates,” “assumes,” “can,” “will,” “meets,”\n“could,” “likely,” “intends,” “might,” “predicts,”\n“seeks,” “would,” “believes,” “estimates,” “plans,”\n“positions,” “continues,” “goals,” “guidance,” or\n“outlook,” or similar expressions. These forward-looking statements\nreflect the company's current expectations about future requirements and\nneeds, results, levels of activity, performance, or achievements. Some of the\nfactors that could cause actual results to differ materially from the\nforward-looking statements contained herein include, without limitation:\nfailure to achieve expected utilization rates, billing rates, and the\nnecessary number of revenue-generating professionals; our ability to realize\nthe expected benefits and potential opportunities of artificial intelligence\n(AI); inability to expand or adjust our service offerings in response to\nmarket demands; our dependence on renewal of client-based services; dependence\non new business and retention of current clients and qualified personnel;\nfailure to maintain third-party provider relationships and strategic\nalliances; inability to license technology to and from third parties; the\nimpairment of goodwill; various factors related to income and other taxes;\ndifficulties in successfully integrating the businesses we acquire and\nachieving expected benefits from such acquisitions; risks relating to privacy,\ninformation security, and related laws and standards; and a general downturn\nor volatility in market conditions, including as a result of current global\ntrade tensions and/or tariffs. These forward-looking statements involve known\nand unknown risks, uncertainties, and other factors, including, among others,\nthose described under “Item 1A. Risk Factors” in Huron's Annual Report on\nForm 10-K for the year ended December 31, 2025 that may cause actual results,\nlevels of activity, performance or achievements to be materially different\nfrom any anticipated results, levels of activity, performance, or achievements\nexpressed or implied by these forward-looking statements. The company\ndisclaims any obligation to update or revise any forward-looking statements as\na result of new information or future events, or for any other reason.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260727120166/en/\n(https://www.businesswire.com/news/home/20260727120166/en/)\n\nMEDIA CONTACT \n\nAllie Bovis\n\nabovis@hcg.com (mailto:abovis@hcg.com)\n\nINVESTOR CONTACT \n\nJohn D. Kelly\n\nInvestor@hcg.com (mailto:Investor@hcg.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBwbhfMVVa","title":"Huron Elects Dr. L. Thomas Richards to Board of Directors","author":"Business Wire","ticker":"HURN","created":"2026-07-27T20:02:00.134Z","tickers":["HURN"],"exchange":"NASDAQ","article_body":"Huron Elects Dr. L. Thomas Richards to Board of Directors\n\nGlobal professional services firm Huron (NASDAQ: HURN) today announced Dr. L.\nThomas Richards was elected to its Board of Directors, effective July 23,\n2026. Dr. Richards is an experienced executive, senior advisor and board\nleader with deep expertise across life sciences and healthcare, capital\nmarkets, and corporate governance. He has a proven track record of helping\norganizations drive growth, unlock innovation, and accelerate value creation.\n\n“We are pleased to welcome Tom to Huron's Board of Directors,” said Hugh\nSawyer\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fir.huronconsultinggroup.com%2Fboard-member%2Fhugh-sawyer&esheet=54577833&newsitemid=20260727120166&lan=en-US&anchor=Hugh+Sawyer&index=1&md5=f0af385f7876d06fb2813f7aa189890c)\n, non-executive chairman of the Huron\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.huronconsultinggroup.com%2F&esheet=54577833&newsitemid=20260727120166&lan=en-US&anchor=Huron&index=2&md5=1210928c5cd5166e8563c309bad9284c)\nboard. “Tom brings a unique combination of senior management, board\nleadership, and capital markets expertise across his roles as an investment\nbanker, life sciences executive, physician, and board director. His global\nperspective, and expertise in evaluating and adopting new innovative\ntechnologies, and extensive governance experience in professional services\nwill be a strong asset to our Board as we continue to advance Huron’s growth\nstrategy to create long-term value for our shareholders.”\n\nDr. Richards most recently served as Chair of the Board of Directors of\nWittKieffer, an executive search and leadership advisory firm serving the\nhealthcare, higher education, and life sciences sectors.\n\nThroughout his career, Dr. Richards has led organizations at the intersection\nof healthcare, technology, and innovation. He previously served as Interim\nChief Executive Officer of One Biomed, a molecular tools company, and Chief\nExecutive Officer of TessArae, a molecular diagnostics company. He advises\nventure capital and private equity investors across the life sciences\nindustry, with a focus on emerging technologies and innovation-driven growth\nand served as a Senior Advisor to Metis Genetics, One Biomed, and Nanomix. He\nalso practiced academic medicine as an emergency physician and assistant\nprofessor at Stanford University and the University of California, San\nFrancisco.\n\nEarlier in his career, Dr. Richards was an investment banker in the mergers\nand acquisitions (M&A) groups of Lazard Frères, UBS, and SG Cowen.\n\nDr. Richards also has extensive governance experience serving on public,\nprivate, and nonprofit boards. He previously served on the board of directors\nof Cowen Group, Inc., a publicly traded financial services firm, and has\nserved as a director of TessArae and One Biomed. He also currently serves on\nthe board of two non-profit organizations, The World Telehealth Initiative and\nthe Surfrider Foundation.\n\n“I am honored to serve on Huron’s Board of Directors,” said Dr. L.\nThomas Richards. \"I look forward to partnering with my fellow directors and\nHuron’s management team to build on the firm’s strong momentum, advance\nits long-term strategy, and help create lasting value for its clients, people,\nand shareholders.”\n\nDr. Richards received an M.D. from Harvard Medical School, an M.Phil. from the\nUniversity of Sydney, and a B.A. from Yale University. He is a board-certified\nphysician in Emergency Medicine.\n\nThe appointment of Dr. Richards to Huron’s board reflects the firm’s\nongoing commitment to its periodic board refreshment process and brings the\nsize of the board to 10 members.\n\nABOUT HURON\n\nHuron is a global professional services firm that collaborates with\norganizations to help solve their most complex challenges and achieve their\nmost ambitious goals. Working across the private and public sectors, we\npartner closely with clients to improve performance, accelerate\ntransformation, and unlock new opportunities for growth.\n\nOur clients choose us because of our deep industry and technical expertise and\nproven track record of turning sound strategies into action. By combining\npractical experience, innovative thinking, and advanced analytics and\ntechnology, Huron helps organizations translate today’s ideas into tangible\nresults and long-term value. Learn more at www.huronconsultinggroup.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.huronconsultinggroup.com%2F&esheet=54577833&newsitemid=20260727120166&lan=en-US&anchor=www.huronconsultinggroup.com&index=3&md5=c88fc50818746719b82a0ba21935dd26)\n.\n\nStatements in this press release that are not historical in nature, including\nthose concerning the company’s current expectations about its future\nresults, are “forward-looking” statements as defined in Section 21E of the\nSecurities Exchange Act of 1934, as amended, and the Private Securities\nLitigation Reform Act of 1995. Forward-looking statements are identified by\nwords such as “may,” “should,” “expects,” “provides,”\n“anticipates,” “assumes,” “can,” “will,” “meets,”\n“could,” “likely,” “intends,” “might,” “predicts,”\n“seeks,” “would,” “believes,” “estimates,” “plans,”\n“positions,” “continues,” “goals,” “guidance,” or\n“outlook,” or similar expressions. These forward-looking statements\nreflect the company's current expectations about future requirements and\nneeds, results, levels of activity, performance, or achievements. Some of the\nfactors that could cause actual results to differ materially from the\nforward-looking statements contained herein include, without limitation:\nfailure to achieve expected utilization rates, billing rates, and the\nnecessary number of revenue-generating professionals; our ability to realize\nthe expected benefits and potential opportunities of artificial intelligence\n(AI); inability to expand or adjust our service offerings in response to\nmarket demands; our dependence on renewal of client-based services; dependence\non new business and retention of current clients and qualified personnel;\nfailure to maintain third-party provider relationships and strategic\nalliances; inability to license technology to and from third parties; the\nimpairment of goodwill; various factors related to income and other taxes;\ndifficulties in successfully integrating the businesses we acquire and\nachieving expected benefits from such acquisitions; risks relating to privacy,\ninformation security, and related laws and standards; and a general downturn\nor volatility in market conditions, including as a result of current global\ntrade tensions and/or tariffs. These forward-looking statements involve known\nand unknown risks, uncertainties, and other factors, including, among others,\nthose described under “Item 1A. Risk Factors” in Huron's Annual Report on\nForm 10-K for the year ended December 31, 2025 that may cause actual results,\nlevels of activity, performance or achievements to be materially different\nfrom any anticipated results, levels of activity, performance, or achievements\nexpressed or implied by these forward-looking statements. The company\ndisclaims any obligation to update or revise any forward-looking statements as\na result of new information or future events, or for any other reason.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260727120166/en/\n(https://www.businesswire.com/news/home/20260727120166/en/)\n\nMEDIA CONTACT \n\nAllie Bovis\n\nabovis@hcg.com (mailto:abovis@hcg.com)\n\nINVESTOR CONTACT \n\nJohn D. Kelly\n\nInvestor@hcg.com (mailto:Investor@hcg.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-07-27T20:02:00.24984931Z","server_sent_at_ms":1785182520249},"received_at":"2026-07-27T20:02:00.498Z","source_url":"https://www.businesswire.com/news/home/20260727120166/en/"},"analysis":{"id":"88572","press_release_id":"99534","analysis_json":{"industry":{"label":"Professional Services","sector":"Industrials"},"redFlags":[],"eventType":"board_change","narrative":"Huron elected Dr. L. Thomas Richards to its Board of Directors, effective July 23, 2026, increasing the board size to 10 members.\n\nDr. Richards is a former investment banker, physician, and executive who most recently served as Chair of WittKieffer, bringing deep expertise in life sciences and corporate governance.\n\nChairman Hugh Sawyer noted that Richards' background in capital markets and technology adoption will support Huron's growth strategy and long-term value creation.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Board addition strengthens capital markets and healthcare capabilities."},"keyFigures":{"customDimensions":{"board_size":10}},"quotedText":"I look forward to partnering with my fellow directors and Huron’s management team to build on the firm’s strong momentum, advance its long-term strategy, and help create lasting value for its clients, people, and shareholders.","namedEntities":{"people":[{"name":"Dr. L. Thomas Richards","role":"Director"},{"name":"Hugh Sawyer","role":"Non-executive Chairman"},{"name":"Allie Bovis","role":"Media Contact"},{"name":"John D. Kelly","role":"Investor Contact"}],"products":[],"companies":[{"name":"Huron","ticker":"HURN"},{"name":"WittKieffer"},{"name":"One Biomed"},{"name":"TessArae"},{"name":"Metis Genetics"},{"name":"Nanomix"},{"name":"Lazard Frères"},{"name":"UBS"},{"name":"SG Cowen"},{"name":"Cowen Group, Inc."},{"name":"The World Telehealth Initiative"},{"name":"The Surfrider Foundation"},{"name":"Stanford University"},{"name":"University of California, San Francisco"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine board refreshment adding a director with significant capital markets and life sciences expertise. The appointment aligns with growth strategy but is not a market-moving event."},"tickerRelevance":{"others":[],"primary":"HURN"},"globalImportance":12,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"board_appointment"}},"event_type":"board_change","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Huron elected Dr. L. Thomas Richards to its Board of Directors, effective July 23, 2026, increasing the board size to 10 members.\n\nDr. Richards is a former investment banker, physician, and executive who most recently served as Chair of WittKieffer, bringing deep expertise in life sciences and corporate governance.\n\nChairman Hugh Sawyer noted that Richards' background in capital markets and technology adoption will support Huron's growth strategy and long-term value creation.","key_figures":{"customDimensions":{"board_size":10}},"named_entities":{"people":[{"name":"Dr. L. Thomas Richards","role":"Director"},{"name":"Hugh Sawyer","role":"Non-executive Chairman"},{"name":"Allie Bovis","role":"Media Contact"},{"name":"John D. Kelly","role":"Investor Contact"}],"products":[],"companies":[{"name":"Huron","ticker":"HURN"},{"name":"WittKieffer"},{"name":"One Biomed"},{"name":"TessArae"},{"name":"Metis Genetics"},{"name":"Nanomix"},{"name":"Lazard Frères"},{"name":"UBS"},{"name":"SG Cowen"},{"name":"Cowen Group, Inc."},{"name":"The World Telehealth Initiative"},{"name":"The Surfrider Foundation"},{"name":"Stanford University"},{"name":"University of California, San Francisco"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-27T20:37:29.500Z","global_importance":12,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap","eventGravity":"board_appointment"}},"durationMs":188824,"modelName":"glm-4.7"}}